Sperogenix Therapeutics 曙方医药

Sperogenix therapeutics 曙方医药 email format

Verified email-pattern data for Sperogenix Therapeutics 曙方医药 is currently limited. You can still use the company insights and contact sections below.
Sperogenix Therapeutics is a platform company dedicated to developing and commercializing rare disease therapeutics in China with focus on mid-to-late clinical stage and commercial stage products. With prioritized therapeutic areas, such as Pulmonary Vascular Disorders, Neurological Disorders, Inherited Metabolic Diseases, and Non-oncology Hematology Disorders, Sperogenix is dedicated to establishing an innovative commercial model tailored to the China rare disease field, in order to provide affordable and reliable products and services to Chinese physicians and patients. Sperogenix was founded in 2019 and is backed by biopharma industry blue chip investors including Lilly Asia Ventures (LAV) and Morningside Venture in the A-round financing.
Looking for a particular Sperogenix Therapeutics 曙方医药 employee's phone or email?

Sperogenix Therapeutics 曙方医药 Questions

Top Sperogenix Therapeutics 曙方医药 Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant